Online

2017 年 05 月 09 日 12:00 下午 - 2017 年 05 月 11 日 2:00 下午

Oversight of Clinical Monitoring: Trends and Strategies

Part 1: Current Trends in Pharmaceutical/Medical Device Development Impacting Monitoring

Session Chair(s)

Lynn  King, MHA

Lynn King, MHA

Consultant

United States

Part 1:
Current Trends in Pharmaceutical/Medical Device Development Impacting Monitoring

•Current clinical development landscape and challenges requiring change
•Define the purpose of monitoring
•Impact of Risk-Based Monitoring (RBM) Approaches
•FDA Guidance on RBM
•EMEA Reflection Paper on Risk-Based Quality Management
•TransCelerate Position Paper on RBM
•Compare RBM approaches in FDA Guidance to TransCelerate
•Advances in technology impacting monitoring
•Selection and training of monitors
•Effective resourcing of monitors

Questions/Answers

获得信息并保持参与

不要错失任何机会——请加入我们的邮件列表,了解DIA的观点和事件。